#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14614	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2365	753.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1560	1560	C	906	C,G	905,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4043	741.2	0	.	n	.	0	T695C	SNP	695	695	T	1244	1244	C	869	C,A,T	865,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4043	741.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1886	1886	A	968	A,T,G	965,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4043	741.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2520	2520	C	826	C,T,G,A	817,5,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4043	741.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2594	2594	A	753	A	753	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24046	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4043	741.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3146	3146	C	853	C,T	852,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2120	folP	855	855	100.0	folP.l15.c30.ctg.1	1820	144.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1170	1172	AGC	204;206;208	A,T;G;C	203,1;206;208	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4992	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3790	163.8	1	SNP	p	S91F	1	.	.	271	273	TTC	782	784	TTC	168;170;169	T;T;C	168;170;169	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4992	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3790	163.8	1	SNP	p	D95G	1	.	.	283	285	GGC	794	796	GGC	179;180;179	G;G,A;C	178;179,1;179	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4992	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3790	163.8	1	SNP	p	G95N	0	.	.	283	285	GGC	794	796	GGC	179;180;179	G;G,A;C	178;179,1;179	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1932	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1815	132.7	1	SNP	p	G45D	0	.	.	133	135	GGC	764	766	GGC	239;241;240	G;G,A;C,G	239;240,1;239,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1100	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1359	100.9	0	.	n	.	0	A197.	DEL	197	197	A	762	762	A	212	A	212	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	191.1	1	SNP	p	D86N	0	.	.	256	258	GAC	793	795	GAC	260;259;262	G;A;C,A	260;259;261,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	191.1	1	SNP	p	S87R	1	.	.	259	261	CGT	796	798	CGT	261;258;258	C,T;G;T	260,1;258;258	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	191.1	1	SNP	p	R87I	0	.	.	259	261	CGT	796	798	CGT	261;258;258	C,T;G;T	260,1;258;258	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	191.1	1	SNP	p	R87W	0	.	.	259	261	CGT	796	798	CGT	261;258;258	C,T;G;T	260,1;258;258	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5160	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3359	191.1	1	SNP	p	S88P	0	.	.	262	264	TCC	799	801	TCC	259;256;255	T;C;C,T	259;256;254,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4320	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3195	168.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1754	1756	GGC	230;231;229	G,C;G,C;C	229,1;230,1;229	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1490	1492	GCA	256;259;262	G;C;A,C	256;259;261,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1493	1495	ATC	264;263;264	A,T;T;C	263,1;263;264	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1505	1507	GTG	271;268;266	G;T;G	271;268;266	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1505	1507	GTG	271;268;266	G;T;G	271;268;266	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2009	2011	ACC	206;205;206	A;C,T,G;C	206;203,1,1;206	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2063	2065	GCG	212;213;215	G;C;G	212;213;215	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2063	2065	GCG	212;213;215	G;C;G	212;213;215	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2186	2188	AGC	221;220;219	A,T;G;C	220,1;220;219	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2195	2197	GGC	203;200;198	G;G;C	203;200;198	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3860	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2920	164.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2213	2215	CCG	208;210;211	C,A;C,G,A;G	207,1;208,1,1;211	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5470	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3527	193.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1797	1799	CCG	217;220;221	C;C,T,G;G,A	217;218,1,1;219,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2318	porA	1146	1146	99.91	porA.l6.c17.ctg.1	2240	129.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	813	813	C	175	C	175	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	418	porB1a	984	100	95.0	porB1a.l15.c30.ctg.1	182	57.7	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	67;67;66	A,T,G;C;G	65,1,1;67;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	418	porB1a	984	100	95.0	porB1a.l15.c30.ctg.1	182	57.7	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	19;16;14	C;A;A	19;16;14	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	A54S	NONSYN	160	162	GCC	609	611	TCC	257;254;255	T,A,G,C;C;C,A	254,1,1,1;254;254,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	V75I	NONSYN	223	225	GTT	672	674	ATT	264;264;265	A;T;T,G	264;264;264,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	714	716	AGC	249;248;246	A;G;C	249;248;246	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	V98I	NONSYN	292	294	GTC	741	743	ATC	234;235;231	A;T;C	234;235;231	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	806	807	CG	177;179	C;G	177;178	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	809	811	CAG	180;180;181	C,T;A;G,C	178,1;179;179,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	813	815	AAA	181;182;184	A;A;A	180;181;183	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	840	842	TAT	202;202;201	T;A;T	202;202;201	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	N134E	NONSYN	400	402	AAT	849	851	GAG	203;204;203	G;A,C;G	202;203,1;202	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	V135F	NONSYN	403	405	GTG	852	854	TTT	201;201;203	T,G;T,G;T	199,1;198,2;202	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	G140K	NONSYN	418	420	GGA	867	869	AAA	211;211;213	A;A;A	211;211;213	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	876	878	GAA	213;216;216	G;A,T;A,G	213;215,1;215,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	900	902	GCA	233;237;237	G,A;C,G;A,G	232,1;236,1;236,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1074	1076	ATG	238;239;238	A;T;G	238;239;238	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	Q213L	NONSYN	637	639	CAG	1086	1088	TTA	238;236;233	T;T,A;A	238;235,1;233	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	S216I	NONSYN	646	648	AGC	1095	1097	ATC	229;227;226	A;T;C,A	229;227;225,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1206	1208	CAA	186;184;183	C,A;A,T,G;A	185,1;182,1,1;183	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	.	INDELS	760	762	ACA	1210	1214	ATCAA	183;181;181;180;179	A;T;C;A;A	183;181;181;180;179	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	.	INDELS	763	764	TG	1217	1219	AGT	177;176;178	A;G;T	177;176;178	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1224	1226	GAT	181;185;186	G;A;T,C	181;185;185,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1332	1334	AGT	235;236;237	A;G;T,C	235;236;236,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1338	1340	GAC	246;246;248	G,C;A;C	245,1;246;248	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1341	1343	TAC	249;250;253	T,G;A,T;C,A	248,1;249,1;252,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	1	SNP	p	G120K	1	.	.	358	360	AAG	806	808	CGG	177;179;179	C;G;G	177;178;178	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	1	SNP	p	D121N	0	.	.	361	363	GAC	809	812	CGC	180;181;180	C,T;G,C;C	178,1;179,1;179	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2746	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1629	202.6	1	SNP	p	A121D	1	.	.	361	363	GAC	809	812	CGC	180;181;180	C,T;G,C;C	178,1;179,1;179	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	300	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	61.0	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	80;80;80	A;C;T	80;80;80	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	300	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	61.0	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	80;80;80	A;G;T,C	80;80;79,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	300	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	61.0	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	80;80;80	G,C;A;C	79,1;80;80	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	300	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	61.0	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	80;80;80	T;A,T;C	80;79,1;80	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9742	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5339	227.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1464	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1487	122.8	1	SNP	p	V57M	1	.	.	169	171	ATG	720	722	ATG	254;256;255	A,C;T;G	253,1;256;255	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
